UNSPSC 51111619: Brequinar

This classification denotes a pyrimidine antagonist and dihydroorotate dehydrogenase inhibitor with the molecular formula C23H15F2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 5XL19F49H6 chemically known as 4-quinolinecarboxylic acid, 6-fluoro-2-(2'-fluoro(1,1'-biphenyl)-4-yl)-3-methyl- but generally known as brequinar, which bears US NIH Compound Identifier 57030. European Medicines Agency schedules Brequinar in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05885MIG.

UNSPSC 51111619 Brequinar is a Commodity code for a specific pharmaceutical product. State and local procurement activity under this code is minimal; the single recent opportunity on record is a Request for Information (RFI) issued by the Texas Health and Human Services Commission in April 2026 that does not actually solicit brequinar itself but rather seeks vendor information about implementing a direct-to-manufacturer prescription program within the state's pharmacy benefit system. The RFI solicits market intelligence regarding vendor capacity to establish direct relationships between state pharmacy programs and pharmaceutical manufacturers, negotiate contracts outside traditional pharmacy benefit manager and group purchasing organization channels, and implement outcomes-based pricing models. This represents exploratory procurement activity rather than a specific drug acquisition; the RFI documentation contains no award values, budget ranges, set-aside designations, or formal evaluation criteria, as the state is gathering foundational information to inform future formal solicitations.

The geographic spread is limited to Texas based on current recent activity. The Texas Health and Human Services Commission RFI (HHS0017013, due April 3, 2026) is the only recent state or local opportunity identified under this code. No other state agencies, counties, municipalities, school districts, or transit authorities appear in the recent-opportunities record. This code shows little relevant recent activity tied to actual brequinar procurement; the tagged opportunity addresses pharmacy program infrastructure and vendor capabilities rather than drug product acquisition or supply contracting.